دورية أكاديمية
أعرض في EDS

Risk factors of diabetes and cancer-specific mortalities in patients with infiltrating ductal carcinoma of the breast: a population-based study.

التفاصيل البيبلوغرافية
العنوان: Risk factors of diabetes and cancer-specific mortalities in patients with infiltrating ductal carcinoma of the breast: a population-based study.
المؤلفون: Elshanbary AA; Faculty of Medicine, Alexandria University, Alexandria., Zaazouee MS; Faculty of Medicine, Al-Azhar University, Assiut., Nourelden AZ; Faculty of Medicine, Al-Azhar University, Cairo, Egypt., Al-Kafarna M; Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine., Matar SG; Faculty of Pharmacy, University of Jordan, Amman, Jordan., Elsaeidy AS; Faculty of Medicine, Benha University, Benha., Ragab KM; Faculty of Medicine, Minia University, Minia, Egypt., Elhady MM; Faculty of Medicine, Benha University, Benha., Albadrani GM; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh., Altyar AE; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University.; Pharmacy Program, Batterjee Medical College, Jeddah., Kensara OA; Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah., Abdel-Daim MM; Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia.; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
المصدر: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) [Eur J Cancer Prev] 2024 Jul 01; Vol. 33 (4), pp. 321-333. Date of Electronic Publication: 2023 Dec 27.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9300837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5709 (Electronic) Linking ISSN: 09598278 NLM ISO Abbreviation: Eur J Cancer Prev Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Lippincott Williams & Wilkins
Original Publication: Oxford, UK : Rapid Communications of Oxford, c1991-
مواضيع طبية MeSH: Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Carcinoma, Ductal, Breast*/mortality , Carcinoma, Ductal, Breast*/pathology , Carcinoma, Ductal, Breast*/therapy , Carcinoma, Ductal, Breast*/epidemiology , SEER Program*/statistics & numerical data, Humans ; Female ; Middle Aged ; Risk Factors ; Aged ; Adult ; Diabetes Mellitus/mortality ; Diabetes Mellitus/epidemiology ; Prognosis ; United States/epidemiology ; Survival Rate ; Follow-Up Studies ; Neoplasm Staging
مستخلص: Background and Aims: Breast cancer is considered one of the most common neoplasms worldwide. Diabetes (DM) increases mortality among postmenopausal patients with breast cancer. Our study aims to identify the risk factors of DM-specific mortality and infiltrating ductal carcinoma (IDC) mortality in patients with IDC of the breast.
Materials and Methods: Data of IDC patients were obtained from the Surveillance, Epidemiology, and End Results database from 1975 to 2016. Independent variables included age, race, marital status, the primary site of IDC, breast subtype, the disease stage, grade, chemotherapy, radiation, and surgery. Kaplan-Meier, Cox and Binary regression tests were used to analyze the data using SPSS software.
Results: A total of 673 533 IDC patients were analyzed. Of them, 4224 died due to DM and 116 822 died due to IDC. Factors that increase the risk of overall, IDC-specific, and DM-specific mortalities include older age, black race, widowed, uninsured, regional and distant stages, grade II and III, and no treatment with chemotherapy or radiotherapy or surgery. Additionally, the IDC mortality increased with separated status, all primary sites, all breast subtypes, and stage IV.
Conclusion: In patients with IDC, controlling DM besides cancer is recommended to reduce the mortality risk. Old, black, widowed, uninsured, regional and distant stages, grade II and III, and no treatment are common risk factors for DM- and IDC-mortality.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: Al-Saeed AH, Constantino MI, Molyneaux L, D’Souza M, Limacher-Gisler F, Luo C, et al. (2016). An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care 39:823–829.
Bhatia D, Lega IC, Wu W, Lipscombe LL (2020). Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis. Diabetologia 63:34–48.
Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. (2012). Diabetes and breast cancer risk: a meta-analysis. Br J Cancer 107:1608–1617.
Calip GS, Yu O, Boudreau DM, Shao H, Oratz R, Richardson SB, et al. (2019). Diabetes and differences in detection of incident invasive breast cancer. Cancer Causes Control 30:435–441.
Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM (2012). Diabetes and cause-specific mortality in a prospective cohort of one million US adults. Diabetes Care 35:1835–1844.
Carter JS, Pugh JA, Monterrosa A (1996). Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125:221–232.
Charlot M, Castro-Webb N, Bethea TN, Bertrand K, Boggs DA, Denis GV, et al. (2017). Diabetes and breast cancer mortality in black women. Cancer Causes Control 28:61–67.
Cocquyt V, Van Belle S (2005). Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol 17:55–60.
Collaborative Group on Hormonal Factors in Breast Cancer (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13:1141–1151.
De Bruijn KM, Arends LR, Hansen BE, Leeflang S, Ruiter R, van Eijck CH (2013). Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg 100:1421–1429.
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. (2019). Breast cancer statistics, 2019. CA Cancer J Clin 69:438–451.
Dianatinasab M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, Rezaianzadeh A (2017). Hair coloring, stress, and smoking increase the risk of breast cancer: a case-control study. Clin Breast Cancer 17:650–659.
Eldin EIZ (2020). 27P Breast cancer primary site and laterality as predictive factors of prognosis: SEER based analysis for survival. Ann Oncol 31:S1251.
Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, et al. (2011). Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 29:54.
Escolar-Pujolar A, Córdoba Doña JA, Goicolea Julían I, Rodríguez GJ, Santos Sánchez V, Mayoral Sánchez E, et al. (2018). The effect of marital status on social and gender inequalities in diabetes mortality in Andalusia. Endocrinol Diabetes Nutr (Engl Ed) 65:21–29.
Fernández-Arce L, Robles-Rodríguez N, Fernández-Feito A, Llaneza-Folgueras A, Encinas-Muñiz AI, Lana A (2022). Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer. Cancer Causes Control 33:271–278.
Fleming ST, Rastogi A, Dmitrienko A, Johnson KD (1999). A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 37:601–614.
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. (2012). Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab 97:E1579–E1639.
Hinyard L, Wirth L, Clancy J, Schwartz T (2017a). The effect of marital status on breast cancer-related outcomes in women under 65: a SEER database analysis. Breast 32:13–17.
Hinyard L, Wirth LS, Clancy JM, Schwartz T (2017b). The effect of marital status on breast cancer-related outcomes in women under 65: a SEER database analysis. Breast 32:13–17.
Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ (2014). Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 174:251–258. 10.1001/jamainternmed.2013.12956. (PMID: 10.1001/jamainternmed.2013.12956)
Huo L, Magliano DJ, Rancière F, Harding JL, Nanayakkara N, Shaw JE, et al. (2018). Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011. Diabetologia 61:1055–1063.
Hwang K-T, Kim J, Jung J, Chang JH, Chai YJ, Oh SW, et al. (2019). Impact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER database. Clin Cancer Res 25:1970–1979.
Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021). In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast Cancer Res 23:17.
Kim HJ, Kim S, Freedman RA, Partridge AH (2022). The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A US SEER database analysis. Breast 61:77–83.
Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA (2010). Risk factors for ductal and lobular breast cancer: results from the nurses’ health study. Breast Cancer Res 12:1–11.
Kposowa AJ, Aly Ezzat D, Breault K (2021). Diabetes mellitus and marital status: evidence from the national longitudinal mortality study on the effect of marital dissolution and the death of a spouse. Int J Gen Med 14:1881–1888.
Krajc K, Miroševič S, Sajovic J, Klemenc Ketiš Z, Spiegel D, Drevenšek G, et al. (2023). Marital status and survival in cancer patients: a systematic review and meta-analysis. Cancer Med 12:1685–1708.
Landrine H, Corral I (2009). Separate and unequal: residential segregation and black health disparities. Ethn Dis 19:179–184.
Larsson SC, Mantzoros CS, Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862.
Lee KN, Torres MA, Troeschel AN, He J, Gogineni K, McCullough LE (2020). Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status. PLoS One 15:e0232581.
Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK, Amir E, et al. (2018). The impact of diabetes on breast cancer treatments and outcomes: a population-based study. Diabetes Care 41:755–761.
Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, et al. (2011). Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev 12:1061–1065.
Lin L, Li Z, Yan L, Liu Y, Yang H, Li H (2021). Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J Hematol Oncol 14:197.
Lipscombe LL, Hux JE, Booth GL (2005). Reduced screening mammography among women with diabetes. Arch Intern Med 165:2090–2095.
Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K (2012). The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer 118:1353–1361.
Ma Y, Hébert JR, Manson JE, Balasubramanian R, Liu S, Lamonte MJ, et al. (2012). Determinants of racial/ethnic disparities in incidence of diabetes in postmenopausal women in the US: the women’s health initiative 1993-2009. Diabetes Care 35:2226–2234.
Makki J (2015). Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol 8:CPath. S31563.
Matou-Nasri S, Aldawood M, Alanazi F, Khan AL (2023). Updates on triple-negative breast cancer in type 2 diabetes mellitus patients: from risk factors to diagnosis, biomarkers and therapy. Diagnostics (Basel) 13:2390.
McBean AM, Yu X (2007). The underuse of screening services among elderly women with diabetes. Diabetes Care 30:1466–1472.
Mullooly M, Khodr ZG, Dallal CM, Nyante SJ, Sherman ME, Falk R, et al. (2017). Epidemiologic risk factors for in situ and invasive breast cancers among postmenopausal women in the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol 186:1329–1340.
Najafi B, Anvari S, Roshan ZA (2013). Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev 14:5811–5816.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. (2021). Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 64:275–287.
van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JWW, Haak HR (2007). Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986–1992.
Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, et al. (2011). Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol 137:975–983.
Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, et al. (2018). Diabetes and overall survival among breast cancer patients in the US military health system. Cancer Epidemiol Biomarkers Prev 27:50–57.
Siegel RL, Miller KD, Jemal A (2018). Cancer statistics, 2018. CA Cancer J Clin 68:7–30.
Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009). Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170–2176.
Williams LA, Nichols HB, Hoadley KA, Tse CK, Geradts J, Bell ME, et al. (2018). Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study. Cancer Causes Control 29:25–32.
Xiong F, Wang J, Nierenberg JL, Van Blarigan EL, Kenfield SA, Chan JM, et al. (2023). Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study. Br J Cancer 129:648–655.
Zhao XB, Ren GS (2016). Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis. Medicine (Baltim) 95:e5602.
Zhou X, Zheng Z, Li Y, Zhao W, Lin Y, Zhang J, et al. (2021). The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study. BMC Cancer 21:1–9.
Zhu X, Heng Y, Zhou L, Zhang M, Cao P, Tao L (2020). Diabetic mortality risk among cancer patients in the United States SEER population, 1975-2016. Endocrine 70:323–330.
تواريخ الأحداث: Date Created: 20240108 Date Completed: 20240606 Latest Revision: 20240606
رمز التحديث: 20240606
DOI: 10.1097/CEJ.0000000000000869
PMID: 38190207
قاعدة البيانات: MEDLINE
الوصف
تدمد:1473-5709
DOI:10.1097/CEJ.0000000000000869